ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT01555164
Brief Title: A Phase 3 Study of Ranolazine in Subjects With Type 2 Diabetes Who Are Inadequately Controlled on Metformin Alone

First Submitted : March 13, 2012
First Submitted that Met QC Criteria : March 13, 2012
First Posted : March 15, 2012 (Estimate)

Results First Submitted : September 17, 2014
Results First Submitted that Met QC Criteria : September 17, 2014
Results First Posted : September 23, 2014 (Estimate)

Certification/Extension First Submitted : January 17, 2014
Certification/Extension First Submitted that Met QC Criteria : January 17, 2014
Certification/Extension First Posted : February 13, 2014 (Estimate)

Last Update Submitted that Met QC Criteria : September 17, 2014
Last Update Posted : September 23, 2014 (Estimate)